Definitive Healthcare Corp. (NASDAQ:DH) Short Interest Up 30.0% in February

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 2,770,000 shares, an increase of 30.0% from the February 13th total of 2,130,000 shares. Currently, 6.8% of the company's shares are short sold. Based on an average trading volume of 823,600 shares, the days-to-cover ratio is currently 3.4 days.

Definitive Healthcare Stock Up 0.9 %

Shares of NASDAQ DH traded up $0.03 during trading hours on Friday, hitting $2.82. The company had a trading volume of 300,045 shares, compared to its average volume of 752,224. The stock has a market capitalization of $317.84 million, a P/E ratio of -0.91, a price-to-earnings-growth ratio of 4.06 and a beta of 1.51. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 1-year low of $2.55 and a 1-year high of $8.35. The firm's 50 day moving average is $4.22 and its 200-day moving average is $4.33.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. On average, analysts expect that Definitive Healthcare will post 0.16 earnings per share for the current fiscal year.

Remove Ads

Institutional Investors Weigh In On Definitive Healthcare

Several hedge funds have recently added to or reduced their stakes in the business. Irenic Capital Management LP lifted its holdings in Definitive Healthcare by 9.2% during the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock valued at $28,783,000 after purchasing an additional 590,009 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company's stock worth $27,058,000 after buying an additional 1,626,813 shares during the period. Dimensional Fund Advisors LP increased its position in Definitive Healthcare by 1.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,863,912 shares of the company's stock worth $7,661,000 after buying an additional 23,410 shares during the period. State Street Corp increased its position in Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company's stock worth $6,257,000 after buying an additional 317,952 shares during the period. Finally, Geode Capital Management LLC increased its position in Definitive Healthcare by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company's stock worth $5,231,000 after buying an additional 39,938 shares during the period. Institutional investors and hedge funds own 98.67% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on DH shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Stephens initiated coverage on Definitive Healthcare in a research note on Friday, December 20th. They set an "equal weight" rating and a $5.00 target price for the company. The Goldman Sachs Group lowered their target price on Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. Finally, Barclays lowered their target price on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research note on Monday, March 3rd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, Definitive Healthcare has a consensus rating of "Hold" and an average price target of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.